Treatments for Dry Age-Related Macular Degeneration
Dry age-related macular degeneration is a common cause of central vision changes in older adults, but treatment now involves more than simple observation. Care may include regular retinal monitoring, lifestyle adjustments, specific supplements for some patients, and newer therapies for geographic atrophy. Understanding what each option can and cannot do helps set realistic expectations and supports informed discussions with an eye care professional.
Changes in the macula can make reading, recognizing faces, and seeing fine detail more difficult, even when side vision remains fairly normal. Dry age-related macular degeneration usually develops gradually, and treatment depends on the stage of disease, the presence of geographic atrophy, and a person’s overall eye health. While no approach reliably restores lost central vision, several strategies may slow progression, protect remaining function, and help people adapt more effectively to everyday tasks.
This article is for informational purposes only and should not be considered medical advice. Please consult a qualified healthcare professional for personalized guidance and treatment.
How drusen affect the retina
In dry age-related macular degeneration, small yellow deposits called drusen build up under the retina. Early disease may cause few noticeable symptoms, but larger or more numerous drusen can signal a greater risk of progression. Over time, some people develop thinning and loss of retinal cells, known as atrophy. When this atrophy expands in the macula, central vision can become blurred or distorted. Understanding whether changes are mild, intermediate, or advanced helps guide treatment decisions and follow-up.
Diagnosis and screening in ophthalmology
Accurate diagnosis starts with a dilated eye exam in an ophthalmology or optometry setting. Eye care professionals may use optical coherence tomography, fundus photography, and other imaging tools to look for drusen, retinal thinning, or fluid that could suggest conversion to wet disease. Screening is especially important for older adults, people with a family history of macular disease, and smokers. Monitoring with an Amsler grid at home may also help detect new distortion, which should prompt a timely medical evaluation.
Do supplements help protect vision?
Supplements can play a role for some patients, but they are not a universal treatment. The AREDS2 formula is commonly recommended for certain people with intermediate disease or advanced changes in one eye because it may reduce the risk of progression to advanced stages. These supplements are not considered a cure, and they are not usually advised as a substitute for a balanced diet or medical follow-up. Decisions about vitamins should account for overall health, smoking history, and possible interactions with other medications.
Lifestyle measures also matter. Not smoking, controlling blood pressure, eating leafy greens and fish, managing cardiovascular risk factors, protecting the eyes from excessive ultraviolet exposure, and staying physically active may support long-term retinal health. These steps do not eliminate the condition, but they can be part of a broader plan to preserve function.
Therapy for geographic atrophy
For many years, treatment for dry disease focused mainly on observation, risk reduction, and visual support. That changed with the introduction of injectable therapy for geographic atrophy, an advanced form of dry age-related macular degeneration. Medicines that target the complement pathway may slow the growth of atrophy in some patients, although they do not reverse damage that has already occurred or fully restore lost vision. Treatment involves repeated eye injections and regular monitoring, and the potential benefits must be weighed against burden, side effects, and the possibility of developing wet macular degeneration.
Not every patient with dry disease is a candidate for these therapies. The location and size of atrophy, the rate of progression, vision in each eye, and the person’s comfort with frequent visits all influence decision-making. A retinal specialist can explain expected outcomes in practical terms, including whether therapy is more likely to preserve reading vision for a longer period rather than improve eyesight that has already declined.
Supporting eyesight in daily life
When central vision loss affects daily activities, low vision care becomes an important part of treatment. Brighter task lighting, high-contrast materials, larger print, electronic magnifiers, screen readers, and customized visual aids can make reading and household tasks easier. Occupational therapy and low vision rehabilitation may help people use their remaining eyesight more efficiently. These practical tools do not treat the retinal disease itself, but they often improve independence and quality of life in meaningful ways.
Another essential step is watching for signs that dry disease may be changing. Sudden distortion, a dark spot in the center of vision, or a rapid drop in reading ability can indicate bleeding or fluid from wet age-related macular degeneration, which requires different treatment. Prompt reporting of new symptoms allows quicker diagnosis and, if needed, treatment with anti-VEGF injections for the wet form.
Treatment for dry age-related macular degeneration is increasingly individualized. Some people benefit most from regular screening, lifestyle changes, and supplements, while others may also consider therapy for geographic atrophy and low vision support. The common goal is to slow damage, preserve useful central vision for as long as possible, and help patients maintain daily function through careful follow-up and realistic planning.